DUSP3 genetic deletion confers M2-like macrophage-dependent tolerance to septic shock

Journal of Immunology

Volumn 194, Issue 10, 2015, Pages 4951-4962

  Singh, Pratibha ^a   Dejager, Lien ^b,c   Amand, Mathieu ^a   Theatre, Emilie ^a   Vandereyken, Maud ^a   Zurashvili, Tinatin ^a   Singh, Maneesh ^a   Mack, Matthias ^d   Timmermans, Steven ^b,c   Musumeci, Lucia ^a   Dejardin, Emmanuel ^a   Mustelin, Tomas ^e,f   Van Ginderachter, Jo A ^b,g   Moutschen, Michel ^a   Oury, Cécile ^a   Libert, Claude ^b,c   Rahmouni, Souad ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^e BURNHAM INSTITUTE   (United States)

^f MEDIMMUNE   (United States)

^g VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE 3; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TUMOR NECROSIS FACTOR; DUSP3 PROTEIN, HUMAN; DUSP3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DUSP3 GENE; ENZYME ACTIVATION; FEMALE; GENE DELETION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFECTION RESISTANCE; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEPTIC SHOCK; ADOPTIVE TRANSFER; ANIMAL; DEFICIENCY; DNA MICROARRAY; FLOW CYTOMETRY; IMMUNOLOGY; KNOCKOUT MOUSE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADOPTIVE TRANSFER; ANIMALS; BLOTTING, WESTERN; DUAL SPECIFICITY PHOSPHATASE 3; FLOW CYTOMETRY; GENE DELETION; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; MACROPHAGES; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SHOCK, SEPTIC; SIGNAL TRANSDUCTION;

EID: 84929104777     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402431     Document Type: Article

References (36)

1. López-Bojórquez, L. N., A. Z. Dehesa, and G. Reyes-Terán. 2004. Molecular mechanisms involved in the pathogenesis of septic shock. Arch. Med. Res. 35: 465-479.
2. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420: 885-891.
3. Rittirsch, D., M. A. Flierl, and P. A. Ward. 2008. Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 8: 776-787.
4. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
5. Kawai, T., and S. Akira. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11: 373-384.
6. Kyriakis, J. M., and J. Avruch. 2012. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol. Rev. 92: 689-737.
7. Alonso, A., J. Sasin, N. Bottini, I. Friedberg, I. Friedberg, A. Osterman, A. Godzik, T. Hunter, J. Dixon, and T. Mustelin. 2004. Protein tyrosine phosphatases in the human genome. Cell 117: 699-711.
8. Tautz, L., D. A. Critton, and S. Grotegut. 2013. Protein tyrosine phosphatases: structure, function, and implication in human disease. Methods Mol. Biol. 1053: 179-221.
9. Liu, Y., E. G. Shepherd, and L. D. Nelin. 2007. MAPK phosphatases - regulating the immune response. Nat. Rev. Immunol. 7: 202-212.
10. Jeffrey, K. L., M. Camps, C. Rommel, and C. R. Mackay. 2007. Targeting dualspecificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat. Rev. Drug Discov. 6: 391-403.
11. Salojin, K., and T. Oravecz. 2007. Regulation of innate immunity by MAPK dual-specificity phosphatases: knockout models reveal new tricks of old genes. J. Leukoc. Biol. 81: 860-869.
12. Ishibashi, T., D. P. Bottaro, A. Chan, T. Miki, and S. A. Aaronson. 1992. Expression cloning of a human dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA 89: 12170-12174.
13. Yuvaniyama, J., J. M. Denu, J. E. Dixon, and M. A. Saper. 1996. Crystal structure of the dual specificity protein phosphatase VHR. Science 272: 1328-1331.
14. Alonso, A., M. Saxena, S. Williams, and T. Mustelin. 2001. Inhibitory role for dual specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activation. J. Biol. Chem. 276: 4766-4771.
15. Rahmouni, S., F. Cerignoli, A. Alonso, T. Tsutji, R. Henkens, C. Zhu, C. Louisdit-Sully, M. Moutschen, W. Jiang, and T. Mustelin. 2006. Loss of the VHR dualspecific phosphatase causes cell-cycle arrest and senescence. Nat. Cell Biol. 8: 524-531.
16. Cerignoli, F., S. Rahmouni, Z. Ronai, and T. Mustelin. 2006. Regulation of MAP kinases by the VHR dual-specific phosphatase: implications for cell growth and differentiation. Cell Cycle 5: 2210-2215.
17. Arnoldussen, Y. J., P. I. Lorenzo, M. E. Pretorius, H. Waehre, B. Risberg, G. M. Maelandsmo, H. E. Danielsen, and F. Saatcioglu. 2008. The mitogenactivated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer. Cancer Res. 68: 9255-9264.
18. Henkens, R., P. Delvenne, M. Arafa, M. Moutschen, M. Zeddou, L. Tautz, J. Boniver, T. Mustelin, and S. Rahmouni. 2008. Cervix carcinoma is associated with an up-regulation and nuclear localization of the dual-specificity protein phosphatase VHR. BMC Cancer 8: 147.
19. Hao, L., and W. M. ElShamy. 2007. BRCA1-IRIS activates cyclin D1 expression in breast cancer cells by downregulating the JNK phosphatase DUSP3/VHR. Int. J. Cancer 121: 39-46.
20. Amand, M., C. Erpicum, K. Bajou, F. Cerignoli, S. Blacher, M. Martin, F. Dequiedt, P. Drion, P. Singh, T. Zurashvili, et al. 2014. DUSP3/VHR is a proangiogenic atypical dual-specificity phosphatase. Mol. Cancer 13: 108.
21. Rittirsch, D., M. S. Huber-Lang, M. A. Flierl, and P. A. Ward. 2009. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 4: 31-36.
22. Arimura, Y., and J. Yagi. 2010. Comprehensive expression profiles of genes for protein tyrosine phosphatases in immune cells. Sci. Signal. 3: rs1.
23. Musumeci, L., M. J. Kuijpers, K. Gilio, A. Hego, E. Théâtre, L. Maurissen, M. Vandereyken, C. V. Diogo, C. Lecut, et al. 2015. Dual-specificity phosphatase 3 deficiency or inhibition limits platelet activation and arterial thrombosis. Circulation. 131: 656-68.
24. Biswas, S. K., and A. Mantovani. 2010. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11: 889-896.
25. Ghosn, E. E., A. A. Cassado, G. R. Govoni, T. Fukuhara, Y. Yang, D. M. Monack, K. R. Bortoluci, S. R. Almeida, L. A. Herzenberg, and L. A. Herzenberg. 2010. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proc. Natl. Acad. Sci. USA 107: 2568-2573.
26. Patterson, K. I., T. Brummer, P. M. O'Brien, and R. J. Daly. 2009. Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem. J. 418: 475-489.
27. Takeda, K., and S. Akira. 2004. TLR signaling pathways. Semin. Immunol. 16: 3-9.
28. Yamamoto, M., and K. Takeda. 2010. Current views of toll-like receptor signaling pathways. Gastroenterol. Res. Pract. 2010: 240365.
29. Symons, A., S. Beinke, and S. C. Ley. 2006. MAP kinase kinase kinases and innate immunity. Trends Immunol. 27: 40-48.
30. Schafer, J. F. 1971. Tolerance to plant disease. Annu. Rev. Phytopathol. 9: 235-252.
31. Schneider, D. S., and J. S. Ayres. 2008. Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat. Rev. Immunol. 8: 889-895.
32. Larsen, R., R. Gozzelino, V. Jeney, L. Tokaji, F. A. Bozza, A. M. Japiassú, D. Bonaparte, M. M. Cavalcante, A. Chora, A. Ferreira, et al. 2010. A central role for free heme in the pathogenesis of severe sepsis. Sci. Transl. Med. 2: 51ra71.
33. Figueiredo, N., A. Chora, H. Raquel, N. Pejanovic, P. Pereira, B. Hartleben, A. Neves-Costa, C. Moita, D. Pedroso, A. Pinto, et al. 2013. Anthracyclines induce DNA damage response-mediated protection against severe sepsis. Immunity 39: 874-884.
34. Porta, C., M. Rimoldi, G. Raes, L. Brys, P. Ghezzi, D. Di Liberto, F. Dieli, S. Ghisletti, G. Natoli, P. De Baetselier, et al. 2009. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc. Natl. Acad. Sci. USA 106: 14978-14983.
35. Mehta, A., R. Brewington, M. Chatterji, M. Zoubine, G. T. Kinasewitz, G. T. Peer, A. C. Chang, F. B. Taylor, Jr., and A. Shnyra. 2004. Infection-induced modulation of m1 and m2 phenotypes in circulating monocytes: role in immune monitoring and early prognosis of sepsis. Shock 22: 423-430.
36. Dumitru, C. D., J. D. Ceci, C. Tsatsanis, D. Kontoyiannis, K. Stamatakis, J. H. Lin, C. Patriotis, N. A. Jenkins, N. G. Copeland, G. Kollias, and P. N. Tsichlis. 2000. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103: 1071-1083.